Gilead at it again giving, https://www.marketwatch
Post# of 148185
(Total Views: 672)
Posted On: 07/10/2020 9:17:53 AM
Gilead at it again giving, https://www.marketwatch.com/story/a-new-gilea...2020-07-10
Notice this The new analysis is not from a randomized, placebo-controlled clinical trial; it stems from a comparative, pre-planned analysis of 312 severely ill participants in a randomized, open-label Phase 3 trial and a real-world retrospective cohort of 818 patients with COVID-19 who had similar clinical attributes to those included in the trial and received remdesivir as part of their treatment.
Notice this The new analysis is not from a randomized, placebo-controlled clinical trial; it stems from a comparative, pre-planned analysis of 312 severely ill participants in a randomized, open-label Phase 3 trial and a real-world retrospective cohort of 818 patients with COVID-19 who had similar clinical attributes to those included in the trial and received remdesivir as part of their treatment.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼